(Reuters) – Merck & Co on Tuesday said the U.S. Food and Drug Administration has again declined to approve Bridion, its drug to reverse the effects of muscle relaxants used in surgery, until the agency receives more data on allergic reactions to the product. Roger Perlmutter, Merck’s research chief, told analysts on a conference call […]
Featured Posts
Rare Disease on Payer’s Minds - Even with the COVID-19 emergency measures, payers still had an eye on the potential flood of gene therapies for rare diseases brewing in the pipeline, and were pondering new ways to pay for them. (Reuters) – Investors betting that Bristol-Myers Squibb will emerge as the leading player in a hot new class of cancer drugs hit the pause button on Tuesday as a rival therapy from Merck & Co showed much higher sales. Bristol shares fell as much as 2.7 percent and closed off 1 percent after reporting sales […]
(Reuters) – French drugmaker Sanofi said on Tuesday that the U.S. Food and Drug Administration has agreed to speed up the review of its drug application for a new Fabry disease treatment. Sanofi said its Genzyme unit was enrolling patients in a mid-stage Phase IIa trial of the “GZ/SAR402671” therapy. Fabry disease is an inherited, […]
(Reuters) – An experimental shingles vaccine from GlaxoSmithKline is effective across all age groups, researchers said on Tuesday, boosting the prospects of a key product in the British drugmaker’s development pipeline. In contrast to Merck’s established Zostavax, currently the only product on the market, GSK’s vaccine HZ/su showed no diminution in efficacy with age, according […]
HOUSTON–(BUSINESS WIRE)–Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that they have received orphan drug designation from the U.S. Food and Drug Administration (FDA) for its lead compound Liposomal Grb-2 for the treatment of acute myeloid leukemia (AML). Orphan drug status provides Bio-Path […]
(Reuters) – Black Americans who switched to a high-fiber African diet for just two weeks saw a dramatic drop in risk factors for colon cancer, a study published on Tuesday found. A group of Africans who went the other way and started eating American food rich in animal proteins and fats saw their risks rise […]
According to a new study, those bullied by peers often suffer even worse long-term mental health outcomes than those maltreated by adults early in life. The effects of both sorts of abuse are well-documented, but this is the first study to examine whether bullying, on its own, results in dire psychological problems later in life […]
If you weren’t quite convinced that you are, at least mostly, what you eat, a new study should help persuade you. Researchers from the University of Pittsburgh, Imperial College London, Wageningen University in the Netherlands, University of Helsinki, University of Illinois, and the University of KwaZulu-Natal in South Africa followed participants in the U.S. and in South Africa, asking each […]
KANSAS CITY, Mo., April 27, 2015 /PRNewswire/ — A study published today in The Lancet Respiratory Medicine and presented at the annual Pediatric Academic Societies Meeting reveals the early results of the clinical usefulness of rapid whole-genome sequencing in neonatal and pediatric intensive care units (NICUs and PICUs). Children’s Mercy Kansas City’s STAT-Seq test helped diagnose […]
Late Monday afternoon Merck released the top line results of TECOS, the cardiovascular outcomes trial with its blockbuster diabetes drug Januvia (sitagliptin). The company said that the trial “achieved its primary endpoint of non-inferiority for the composite cardiovascular (CV) endpoint.” Merck announced only one additional detail: “Among secondary endpoints,” they reported, “there was no increase […]